Irajizad, E., Han, C. Y., Celestino, J., Wu, R., Murage, E., Spencer, R., . . . Fahrmann, J. F. (2022). A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses. Clinical cancer research, 28(21), 4669. https://doi.org/10.1158/1078-0432.CCR-22-1113
Citace podle Chicago (17th ed.)Irajizad, Ehsan, et al. "A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses." Clinical Cancer Research 28, no. 21 (2022): 4669. https://doi.org/10.1158/1078-0432.CCR-22-1113.
Citace podle MLA (9th ed.)Irajizad, Ehsan, et al. "A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses." Clinical Cancer Research, vol. 28, no. 21, 2022, p. 4669, https://doi.org/10.1158/1078-0432.CCR-22-1113.